HAWA Facial Diagnostic Mask
Redefining facial cancer detection with AI-powered photonic imaging.
A non-invasive, intelligent diagnostic solution designed for rapid detection, mapping, and monitoring of facial tumours, scars, and skin abnormalities.
What is HAWA
HAWA by Cellunoma is an AI-enabled photonic facial diagnostic mask that captures detailed facial data and transforms it into actionable clinical insights.
Designed for modern healthcare environments, HAWA enables clinicians to detect abnormalities earlier, assess risks more accurately, and monitor changes over time—all through a fast, non-invasive scanning process.
Visionary Impact
HAWA transforms facial diagnostics by shifting care from subjective visual inspection to continuous, objective, and data-driven analysis.
By combining advanced photonic sensing with explainable AI, HAWA delivers real-time detection and interpretable risk scoring—making early diagnosis more scalable, accessible, and reliable.
Advanced Photonic Imaging
HAWA captures multiple layers of facial data in a single scan:
This allows clinicians to detect subtle changes that are not visible through standard examination.
Explainable AI
HAWA’s AI models go beyond detection—they provide clarity.
This ensures transparency and builds trust in every diagnosis.
Key Capabilities
Non-invasive multimodal imaging
AI-powered lesion detection and risk scoring
Visual explainability overlays
One-button guided workflow
Ergonomic and portable design
Secure integration with EHR systems
Sustainable, energy-efficient design
Clinical Applications
HAWA is suitable for a wide range of healthcare settings:
Primary care
Dermatology
Oncology
Telemedicine
Community screening programs
Oncology
Why HAWA
HAWA enables clinicians to move beyond limitations of traditional visual assessment by providing consistent, data-driven insights that improve diagnostic confidence and patient outcomes.